ADVFN US – Market Content Editor
-
Oil Prices Hold Gains as Traders Await Further U.S. Trade Deals and Monitor Supply Shifts
Oil prices remained stable during Friday’s Asian trading session, following notable gains on Thursday, as markets looked ahead to possible new U.S. trade agreements and supply disruptions from Russia. The price action reflects cautious optimism amid shifting geopolitical and economic developments. At 21:31 ET (01:31 GMT), Brent crude futures for September delivery ticked up 0.2%…
-
Stock Market Wrap: S&P 500, Nasdaq Notch Record Highs on Alphabet Surge
The S&P 500 and Nasdaq closed at fresh record highs Thursday, lifted by renewed optimism over trade negotiations and a strong earnings-driven rally in Alphabet. At the close of trading (4:00 p.m. ET), the Dow Jones Industrial Average dropped 316 points, or 0.7%, while the S&P 500 edged up 0.1%, and the Nasdaq Composite rose…
-
NASDAQ, S&P Hit Fresh Record Closing Highs
Wall Street turned in a mixed performance on Thursday after a strong session a day earlier, with the NASDAQ and the S&P 500 opening higher and hitting fresh record closing highs. Conversely, the Dow opened in the red and remained under water throughout the day, weighed by losses from heavyweight IBM, which may be facing…
-
Atara Biotherapeutics shares soar after FDA accepts BLA for tab-cel
Atara Biotherapeutics Inc (NASDAQ:ATRA) saw its stock jump 7% following the U.S. Food and Drug Administration’s acceptance of its Biologics License Application (BLA) for tabelecleucel (tab-cel). The BLA seeks approval for tab-cel as a standalone treatment for adults and children aged two and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have…
-
Biovie shares climb as Alzheimer’s drug shows promising age deceleration effects
Biovie Inc (NASDAQ:BIVI) shares surged 7.3% after unveiling encouraging results for its Alzheimer’s treatment bezisterim at a recent conference in Rome. The clinical-stage biotech firm reported that bezisterim significantly slowed biological aging in Alzheimer’s patients compared to placebo during its Phase 3 trial. After 30 weeks, treated patients showed age deceleration of up to 4.24…
-
Bloom Energy shares jump after teaming up with Oracle for data center power
Bloom Energy (NYSE:BE) saw its stock surge 15% following news of a collaboration with Oracle (NYSE:ORCL) to supply onsite power for Oracle Cloud Infrastructure (OCI) data centers across the U.S. Under the partnership, Bloom will deploy its fuel cell technology at selected OCI facilities, capable of delivering highly reliable, cost-effective power for an entire data…
-
Aeye shares skyrocket after NVIDIA integrates Apollo lidar into DRIVE AGX system
Aeye Inc (NASDAQ:LIDR) saw its stock jump 270% following the announcement that its flagship Apollo lidar has been fully incorporated into NVIDIA’s (NASDAQ:NVDA) DRIVE AGX platform, a key element of NVIDIA’s autonomous vehicle technology suite. This integration provides Aeye with direct access to NVIDIA’s network of leading automakers who are advancing self-driving and driver-assistance systems.…
-
Norfolk Southern shares climb amid confirmation of merger talks with Union Pacific
Norfolk Southern Corporation (NYSE:NSC) saw its stock rise 3.4% following confirmation that it is in “advanced discussions” with Union Pacific Corporation (NYSE:UNP) about a possible merger. Meanwhile, Union Pacific shares slipped 1%, and competitor CSX Corporation (NASDAQ:CSX) gained 3.3% on the news. The announcement from both companies validates media reports from the previous week, including…
-
Imax surpasses earnings forecasts amid booming box office results
Imax Corp (NYSE:IMAX) posted second-quarter earnings that outperformed analyst expectations, fueled by record-breaking North American box office returns and robust growth in its global network. The company, renowned for its premium cinema technology, reported adjusted earnings per share of $0.26 for the quarter ended June 30, beating the $0.21 consensus estimate. Revenue reached $91.7 million,…
-
Phinia shares climb after Q2 earnings significantly beat forecasts
Phinia Inc. (NYSE:PHIN), known for its expertise in premium fuel and electrical systems as well as aftermarket solutions, posted second-quarter results that surpassed analyst predictions by a wide margin, boosting its stock by 2.2% following the announcement. For the quarter ending June 30, 2025, Phinia reported adjusted earnings per share of $1.27, comfortably exceeding the…